Kleschevnikov A - Search Results

1

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

Faizi M, Bader PL, Tun C, Encarnacion A, Kleschevnikov A, Belichenko P, Saw N, Priestley M, Tsien RW, Mobley WC, Shamloo M. Faizi M, et al. Among authors: kleschevnikov a. Neurobiol Dis. 2011 Aug;43(2):397-413. doi: 10.1016/j.nbd.2011.04.011. Epub 2011 Apr 17. Neurobiol Dis. 2011. PMID: 21527343 Free PMC article.

2

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.

Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC. Kleschevnikov AM, et al. J Neurosci. 2004 Sep 15;24(37):8153-60. doi: 10.1523/JNEUROSCI.1766-04.2004. J Neurosci. 2004. PMID: 15371516 Free PMC article.

3

Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

Kleschevnikov AM, Belichenko PV, Gall J, George L, Nosheny R, Maloney MT, Salehi A, Mobley WC. Kleschevnikov AM, et al. Neurobiol Dis. 2012 Feb;45(2):683-91. doi: 10.1016/j.nbd.2011.10.009. Epub 2011 Oct 17. Neurobiol Dis. 2012. PMID: 22062771 Free PMC article.

4

Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.

Kleschevnikov AM, Belichenko PV, Faizi M, Jacobs LF, Htun K, Shamloo M, Mobley WC. Kleschevnikov AM, et al. J Neurosci. 2012 Jul 4;32(27):9217-27. doi: 10.1523/JNEUROSCI.1673-12.2012. J Neurosci. 2012. PMID: 22764230 Free PMC article.

5

Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

Kleschevnikov AM, Yu J, Kim J, Lysenko LV, Zeng Z, Yu YE, Mobley WC. Kleschevnikov AM, et al. Neurobiol Dis. 2017 Jul;103:1-10. doi: 10.1016/j.nbd.2017.03.009. Epub 2017 Mar 22. Neurobiol Dis. 2017. PMID: 28342823 Free PMC article.

6

Discoveries in Down syndrome: moving basic science to clinical care.

Kleschevnikov AM, Belichenko PV, Salehi A, Wu C. Kleschevnikov AM, et al. Prog Brain Res. 2012;197:199-221. doi: 10.1016/B978-0-444-54299-1.00010-8. Prog Brain Res. 2012. PMID: 22541294 Review.

7

GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App.

Mojabi FS, Fahimi A, Moghadam S, Moghadam S, Windy McNerneny M, Ponnusamy R, Kleschevnikov A, Mobley WC, Salehi A. Mojabi FS, et al. Among authors: kleschevnikov a. Hippocampus. 2016 Dec;26(12):1641-1654. doi: 10.1002/hipo.22664. Epub 2016 Oct 24. Hippocampus. 2016. PMID: 27701794

8

Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome.

Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, Mobley WC. Salehi A, et al. Among authors: kleschevnikov a. Sci Transl Med. 2009 Nov 18;1(7):7ra17. doi: 10.1126/scitranslmed.3000258. Sci Transl Med. 2009. PMID: 20368182

9

Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.

Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC. Belichenko PV, et al. Among authors: kleschevnikov am. J Comp Neurol. 2004 Dec 13;480(3):281-98. doi: 10.1002/cne.20337. J Comp Neurol. 2004. PMID: 15515178

10

Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.

Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC. Belichenko PV, et al. Among authors: kleschevnikov am. J Comp Neurol. 2007 Oct 1;504(4):329-45. doi: 10.1002/cne.21433. J Comp Neurol. 2007. PMID: 17663443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page